Search results
Healthy at Every Size? Here's What Doctors Look for Beyond BMI
Verywell Health· 2 days agoPeople with chronic diseases, in particular, shouldn't place too much importance on BMI, Gitomer...
I Choose To Win: Hina Khan Cuts Her Hair Short Amid Breast Cancer Treatment
Latest India News· 14 hours agoNew Delhi: Actress Hina Khan, who is currently battling stage 3 breast cancer, took to her Instagram...
Hina Khan, undergoing cancer treatment, cuts her hair with no tears in eyes so that mother stays...
Tribune India· 1 day agoActor Hina Khan who opened up about her battle with breast cancer recently posted a video of herself...
Signum Surgical’s BioHealx technology obtains FDA clearance
Medical Device Network· 19 hours agoSignum Surgical has secured De Novo clearance from the US Food and Drug Administration (FDA) for its...
Sirnaomics concludes Phase I trial of pancreatic cancer treatment
Clinical Trials Arena· 4 days agoIt was designed to assess the safety, tolerability, and anti-tumour activity of STP707, using...
Radiation Biodosimetry: the ABCs of responding to a mass radiological event
The Hindu· 5 hours agoAfter a large-scale radiological event, such as an Improvised Nuclear Device or reactor accident, it...
Scientifically Speaking | The life-saving potential of deadly venoms
Hindustan Times· 3 hours agoThe Gila monster's unique adaptation to efficiently regulate glucose piqued scientific curiosity,...
Will Narayana Health's mediclaim plan 'Aditi' make health insurance palatable - CNBC TV18
CNBC TV18· 2 hours agoThe idea of hospital owned health insurance company is not new. In the US, many hospitals have managed healthcare schemes akin to Aditi of Narayana Health. Combining the two brings synergy & ...
Kerala boy dies of rare brain-eating amoeba infection; third death in two months
The Hindu· 22 hours agoA 12-year-old boy from Feroke, who had been undergoing treatment for primary amoebic...
With revised IPO pitch, Artiva touts ‘natural killer’ cell therapy for autoimmune disease
BioPharma Dive· 4 days agoLike many of its cell therapy peers, Artiva, which originally sought an IPO in 2021, has shifted its...